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ABSTRACT Alcohol use disorders are inﬂuenced by many interacting genetic and environmental factors.
Highlighting this complexity is the observation that large genome-wide association experiments have
implicated many genes with weak statistical support. Experimental model systems, cell culture and animal,
have identiﬁed many genes and pathways involved in ethanol response, but their applicability to the
development of alcohol use disorders in humans is undetermined. To overcome the limitations of any single
experimental system, the analytical strategy used here was to identify genes that exert common phenotypic
effects across multiple experimental systems. Speciﬁcally, we (1) performed a mouse linkage analysis to
identify quantitative trait loci that inﬂuence ethanol-induced ataxia; (2) performed a human genetic
association analysis of the mouse-identiﬁed loci against ethanol-induced body sway, a phenotype that is not
only comparable to the mouse ethanol-ataxia phenotype but is also a genetically inﬂuenced endopheno-
type of alcohol use disorders; (3) performed behavioral genetic experiments in Drosophila showing that ﬂy
homologs of GPC5, the member of the glypican gene family implicated by both the human and mouse
genetic analyses, inﬂuence the ﬂy’s response to ethanol; and (4) discovered data from the literature dem-
onstrating that the genetically implicated gene’s expression is not only temporally and spatially consistent
with involvement in ethanol-induced behaviors but is also modulated by ethanol. The convergence of these
data provides strong support to the hypothesis that GPC5 is involved in cellular and organismal ethanol
response and the etiology of alcohol use disorders in humans.
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The etiologyofalcohol use disorders (AUD) involvesthe interactionof
many genetic, environmental and behavioral factors (Bierut 2011;
Goldman et al. 2005; Kimura and Higuchi 2011). Two approaches
have been taken to reduce this complexity and make the genetics of
AUDs more experimentally tractable. Animal and cell models provide
the simplest, most ﬂexible experimental systems, but their relevance to
the human disorder is a concern. In humans, efforts have been made
to develop endophenotypes; simpler, intermediate phenotypes predic-
tive of AUD development but more directly inﬂuenced by genetic
variation (Gottesman and Gould 2003). One prominent AUD endo-
phenotype is a low level of response (LR) to ethanol. Low LR is
genetically inﬂuenced (Heath and Martin 1992; Madden et al. 1995;
Martin et al. 1981) and predicative of later AUD development (Quinn
and Fromme 2011; Schuckit and Smith 2000), and independent stud-
ies have demonstrated genetic association of alcohol dependence and
ethanol LR to several polymorphisms, including the same nicotinic
receptor locus (Joslyn et al. 2008; Wang et al. 2008).
Recent genome-wide association (GWA) studies have highlighted
the genetic complexity of AUDs. Large surveys involving hundreds to
thousands of subjects identiﬁed a single intergenic locus marked by
rs7590720 that barely reached statistical signiﬁcance after correcting
for multiple tests (Bierut et al. 2010; Edenberg et al. 2010; Joslyn et al.
2010; Treutlein et al. 2009). A recent meta-analysis of over 45,000
individuals uncovered a different marker, rs6943555 in the AUTS2
gene, which just reaches statistical signiﬁcance (Schumann et al. 2011).
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the heritability have been observed in other genetically inﬂuenced
behavioral disorders. This has been interpreted to mean that the pop-
ulation genetic susceptibility is either expressed through a large num-
ber of alleles common in the population that individually confer a very
small risk and/or alleles that confer a larger individual risk but are rare
in the population and are thus not captured by association with the
common SNPs used in GWA studies (Manolio et al. 2009; Yang et al.
2010). Theoretically, discovering such susceptibility alleles will require
very large (hundreds of thousands) subject samples, combined with
whole genome sequencing, to enable the genotyping of rare alleles. In
practice, such surveys are years in the future: the samples must be
collected; sequencing technology needs to further mature; and analysis
methods need to be further developed.
Cell and animal models used to evaluate the genetic contributions
to AUD risk also face interpretational challenges. Cell culture models
have demonstrated that gene expression and cellular signaling are
altered by exposure to alcohol [reviewed by Moonat et al. (2010)].
While such in vitro studies enable experimental dissection of cellular
ethanol response, it is not clear that the cellular stress response to
a sublethal dose of ethanol shares mechanisms with human AUDs.
Rodent models have been widely used because these animals can be
taught complex alcohol-related behaviors that can then be manipu-
lated and evaluated by pharmacological, genetic, and electrophysio-
logical techniques [reviewed by Lovinger and Crabbe (2005) and
Stuber et al. (2010)]. However, the applicability of the rodent behav-
iors to the human condition is difﬁcult to establish. Invertebrate mod-
els of ethanol response, speciﬁcally Drosophila melanogaster and
Caenorhabditis elegans, afford greater genetic manipulability than
rodents (Wolf and Heberlein 2003), enabling detailed genetic path-
ways inﬂuencing the behavior to be constructed. However, even more
so than rodent experiments, relating invertebrate behaviors to human
ethanol response is challenging.
In this article, we use a cross-species experimental analysis
approach, reasoning that if multiple experimental models suggest
the same mechanism, we have increased our chances of discovering an
etiologically signiﬁcant component of AUDs. To this end, we ﬁrst
analyzed mouse and human genetic data identifying a candidate gene
putatively involved in ethanol response in both species. We then
gained further experimental support for the candidate gene by
determining whether functionally disruptive alleles of the Drosophila
homologs alter the ﬂy’s response to ethanol. Through this approach,
we identiﬁed GPC5, a member of the glypican gene family. Glypicans
are well characterized as modulators of developmental signaling path-
ways, such as Wnts, Hedgehogs, and Bone Morphogenic Proteins
[reviewed by Selleck (2000)]. Intriguingly, evidence is now accumu-
lating that these same pathways participate not only in neural de-
velopment but also in synaptic maintenance and plasticity, leading
to the hypothesis that they are involved in the expression of behavioral
phenotypes (Budnik and Salinas 2011; Farías et al. 2010; Ille and
Sommer 2005; Marqués 2005; Okerlund and Cheyette 2011; Salinas
2005).
MATERIALS AND METHODS
Phenotype selection
Finding a phenotype that is related to alcohol dependence (AD) and
comparable across humans, mice, and ﬂies was central to this analysis.
While AD cannot be accurately modeled in mice and ﬂies, acute
response to ethanol ingestion is similar between these organisms, and
in humans, alcohol response is predictive of later AUD development
(Erblich and Earleywine 1999; Pollock 1992; Quinn and Fromme
2011; Schuckit and Smith 1996; Schuckit and Smith 2000; Schuckit
et al. 2000; Schuckit et al. 1996). We compared locomotor responses
to ethanol: body sway in humans, ataxia in mice, and locomotor
activity in ﬂies.
BXD ethanol-induced ataxia QTL interval mapping
BXD recombinant inbred mouse data were retrieved and analyses
were performed using the WebQTL (www.genenetwork.org)d a t aa n d
analysis suite (Wang et al. 2003). GeneNetwork is an online data
repository with integrated computational tools designed to allow users
to explore complex genetic networks by integrating data from dif-
ferent sources. The BXD resource (a small subset of the collected
data) contains over 2800 measured phenotypes, which were contrib-
uted by hundreds of scientists, all linked to genotypes, providing an
easily accessible tool to genetically map traits of interest. Phenotypes
were selected by searching the BXD phenotype database using the
search strings “ethanol AND ataxia” as well as “alcohol AND ataxia,”
From the returned list of phenotypes, those that described ataxic re-
sponse to the administration of ethanol were selected for interval
mapping.
Ethanol-induced ataxia QTL were mapped using the Interval
Mapping module. A likelihood ratio statistic (LRS) was calculated for
each marker using 1000 permutations. LRS values were converted to
the log of the odds (LOD) ratio to be consistent with human genetic
reporting norms: LOD ¼ LRS/4.61.
Mouse human synteny and marker selection
Mouse chromosomal intervals yielding suggestive linkage for an
ethanol-induced ataxia phenotype had their human syntenic counter-
part identiﬁed using data collected and presented by the comparative
genomics functions of Ensembl (www.ensembl.org). The proximal-
and distal-most markers exhibiting suggestive linkage deﬁned the limits
of mouse ethanol ataxia QTL. Using Ensembl’s mouse genome refer-
ence NCBIM37, all genes, either wholly or partially within the deﬁned
QTL, were identiﬁed. Using the Ensembl comparative genomics
module, the syntenic human genes (genome reference GRCh37) were
identiﬁed. Human SNPs were selected for analysis if located within
as y n t e n i cg e n ea sd e ﬁned by its transcript plus 100 kb of ﬂanking
sequence. All analyzed genotypes were derived from the Illumina
HumanCNV370-Duo DNA Analysis BeadChip.
Subjects
The human subjects genotyped and phenotyped in this study are part
of the San Diego Sibling Pair investigation. Subjects were collected
under a protocol approved by the Human Subjects Protection
Committee of the University of California, San Diego (UCSD) and
is described in greater detail elsewhere (Schuckit et al. 2005; Wilhelm-
sen et al. 2003). Participants, ages 18–25, were selected from UCSD
students who responded to a randomly mailed questionnaire and who
met the following criteria: (1) had a minimum family size of two
siblings, male or female, 18–25 years old; (2) had consumed alcohol
but had NEVER BEEN alcohol dependent; (3) had at least one parent
who met the criteria for alcohol dependence using the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV-TR) (American Psy-
chiatric Association 2000); (4) had never met criteria for antisocial
personality disorder or any DSM-IV Axis I psychiatric condition. In
addition to collecting further questionnaire data, selected subjects were
given an alcohol challenge in a laboratory setting to measure their
responses to an approximately 0.75 ml/kg of ethanol consumed within
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blood alcohol levels). Body sway was measured using a harness at-
tached to the chest at the level of the axilla from which two perpen-
dicular ropes extended forward and to the left side, passing over
pulleys that measured the number of centimeters of movement
per minute as gathered through three 1 min evaluations at each time
point (Schuckit and Gold 1988). Anterior-posterior body sway (BSA)
at the time of peak alcohol effect (60 min) was tested for genetic
marker association in our analyses. To reduce ethnic heterogeneity,
only Caucasian subjects were analyzed. In total, 367 subjects, 134
males and 233 females, were selected from 186 independent families:
38 singleton families; 121 two-sibling families; 23 three-sibling fami-
lies; 3 four-sibling families; and a single six-sibling family. The actual
number of subjects per marker-phenotype analysis varied slightly be-
cause of missing genotype and phenotype data.
Subjects were not consented for release to public databases. Data
may be available for sharing under a conﬁdential agreement between
a requestor and the authors.
DNA preparation and genotyping
DNA was extracted from blood specimens within 5 days of the draw
using Gentra Puregene reagents and protocols (http://www1.qiagen.
com). Extracted DNA was quantiﬁed using the Pico Green method
(Molecular Probes/Invitrogen), and all DNA solutions were normal-
ized to a common concentration for genotyping assays. Genotyping
was carried out using the Illumina HumanCNV370-Duo DNA Anal-
ysis BeadChip. Genotype generation and quality control were per-
formed by deCODE Genotyping Service (http://www.decode.com/).
Human association analysis
Because BSA is not normally distributed (skewness and kurtosis: 1.29
and 2.28), it was corrected for non-normality using the Box-Cox
transformation (Box and Cox 1964; Venables and Ripley 2002). The
scores were then scaled to mean ¼ 0a n dS D¼ 1 to make them
comparable essentially as Z-scores.
Association tests were performed in R (R Development Core Team
2011) with the lmekin function of the kinship package (Atkinson and
Therneau 2008). This function provides a linear mixed-effects model
whereby the genetic relatedness among individuals (based on the kin-
ship coefﬁcient) is incorporated into the covariance structure of the
random effects. This adjusts the model ﬁt and compensates for the
fact that the siblings are related and, therefore, so are their genotypes
and phenotypes, which would otherwise violate the assumption of
independent observations in a linear regression model.
The ﬁxed-effects portion of the model was used for testing the
association between a single SNP and BSA. The SNP was treated in R
as a factor with three levels (categories), which is similar to coding the
major homozygotes as 1/1, the heterozygotes as 0/1, and the minor
homozygotes as 0/0. For each SNP, two tests were performed to
determine if a given genotype class differed in its average phenotype
from the other genotypes. The test compared (a) the major
homozygotes (1/1) and the heterozygotes (0/1), and (b) the major
homozygotes (1/1) and the minor homozygotes (0/0). Tests (a) and
(b) were performed by testing the signiﬁcance of the regression
coefﬁcients from zero, of the heterozygote term and the minor
homozygote term, while holding the major homozygote coefﬁcient
constant at zero. For rare SNPs, minor homozygote individuals are
often not present in the sample, in which case, only test (a) was
available for the SNP. In all cases, the Wald test was used to examine
the signiﬁcance of the regression coefﬁcients.
The large number of tests performed in the analysis required that
the nominal P-values be adjusted for multiple testing. For this, false
discovery rate (FDR) q-values were calculated using the method de-
scribed by Storey and Tibshirani (2003).
Drosophila behavioral experiments
Drosophila strains were maintained on standard cornmeal/molasses/
yeast media at 25C and 70% humidity with an approximately 16-hr/
8-hr light/dark schedule. All strains were outcrossed for ﬁve genera-
tions to the Berlin genetic background strain carrying the w1118 eye-
color marker. Strain sources were dallyMB950 (MB00950: Bloomington
Stock Center), dally80 (Xinhua Lin), dlpf03537 (Exelixis/Harvard), and
dlp1 (Scott Selleck).
Ethanol-stimulated locomotor activity and sedation kinetics were
determined as previously described (Kong et al. 2010; Rothenﬂuh
et al. 2006; Wolf et al. 2002). Ethanol vapor was mixed with a humid-
iﬁed air stream at set ratios to achieve a ﬁnal ﬂow rate of 5.5 L/min
and was delivered to individual exposure chambers, each containing
a group of 20 genetically identical ﬂies. For locomotor activity, ﬂies
were ﬁlmed just prior to and during a 25 min exposure to 47% ethanol
vapor. For sedation kinetics, ﬂies were exposed to 67% ethanol vapor,
and the number of ﬂies that lost the ability to right themselves was
counted at 3 min intervals. All behavioral experiments were repeated
on separate days with ﬂies derived from separate crosses.
Figure 1 Flowchart of the experimental strategy leading to the
identiﬁcation of GPC5 as a participant in ethanol-induced behaviors.
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from ﬂy heads according to the manufacturer’s instructions (Applied
Biosystems) on an ABI PRISM 7900 Sequence Detection System,
using expression levels of RpL32 as a standard to normalize sample
concentrations. TaqMan probesets (Applied Biosystems) used in this
study were dally: Dm01822385_g1, dlp: Dm01798599_g1, and RpL32:
Dm02151827_g1.
Ethanol absorption was measured by exposing groups of 25
ﬂi e st oe i t h e re t h a n o lv a p o r( 4 7 % )o rh u m i d i ﬁed air for 30 min.
Flies were immediately frozen on dry ice, and the ethanol con-
centration in whole-ﬂy homogenates was measured with an alcohol
dehydrogenase–based spectrophotometric assay (Diagnostic Chemi-
cals, Ltd.).
RESULTS
Data analysis followed the logic presented in Figure 1. First, mouse
ethanol response QTL were mapped in the recombinant inbred strain
BXD, a strain constructed from the parental strains C57/B6 and DBA,
which has been extensively phenotyped for alcohol-related behaviors.
We limited our analysis to ethanol-induced ataxia as our ultimate goal
was to compare the BXD result with human data. Ethanol-induced
ataxia is a phenotypic measure held in common between mouse and
human. All BXD data and QTL interval mapping were performed
using the tools available on the genenetwork.org website as described
in Materials and Methods. Twelve phenotypes comparable to the
human body sway phenotype were present in the GeneNetwork da-
tabase and were analyzed (Table 1).
Ethanol-induced ataxia QTL were mapped using the Interval
Mapping module of GeneNetwork. LRS/LOD scores were calculated
using 1000 permutations. The algorithm deﬁnes two statistical
thresholds, suggestive and signiﬁcant,a sd e ﬁned by Lander and Kru-
glyak (1995). While no signiﬁcant linkages were discovered, 10 of the
12 phenotypes deﬁned 13 suggestive ethanol-induced ataxia QTL (Ta-
ble 2).
All suggestive loci had their syntenic human region tested for
genetic association to ethanol-induced anterior-posterior body sway
(BSA). Using the comparative genomics functions of Ensembl, all
human genes syntenic with the mouse loci were identiﬁed. Human
subjects had been genotyped previously using the Illumina
HumanCNV370-Duo genotyping array. Marker SNPs were chosen
for analysis based on location within the genomic limits for the
gene’s transcript plus 100 kb ﬂanking the transcription start and
stop sites. We thus had markers spanning the transcripts of the
n Table 1 BXD phenotypes analyzed for genetic linkage
Article PMID GeneNetwork ID Description
10656187 10042 Ethanol response (2.5 g/kg ip), ataxia, screen test sensitivity measured as
the latency to fall, saline response minus ethanol response [seconds] by
K. E. Browman and colleagues
6683363 10078 Ethanol response (dose, ip), ataxia on grid test, 2 to 10 min after injection
[errors/run] by J. C. Crabbe and colleagues
8627537 10144 Ethanol sensitivity, initial ethanol-induced ataxia, onset threshold [mg/kg]
by E. J. Gallaher and colleagues
8627537 10145 Ethanol response (dose route), maximal threshold to ethanol-induced ataxia
[mg/ml] by E. J. Gallaher and colleagues
12183685 10347 Ethanol response (1.75 g/kg ip), initial sensitivity measured by blood
ethanol concentration (BEC, retrobulbar bleed) at loss of balance using a
dowel test (BEC time 0) [mg % ethanol] by S. L. Kirstein and colleagues
12183685 10349 Ethanol response (1.75 mg/kg ip), time to ataxia measured as loss of
balance using a dowel test (Loss corresponds to BEC time 0) [min] by
S. L. Kirstein and colleagues
12183685 10350 Ethanol response (1.75 mg/kg ip), duration of ataxia following the ﬁrst
ethanol injection using a dowel test (Regain Test 1 corresponds to BEC1)
[min] by S. L. Kirstein and colleagues
8627538 10497 Ethanol response (2 g/kg ip), acute ataxia, difference between day 3 (ﬁrst
ethanol treatment) and day 2 (saline baseline) in the chronic drug group
[n grid test errors/10 min test] by T. J. Phillips and colleagues
8627538 10498 Ethanol response (2 g/kg ip), acute ataxia measured using grid test
(Accuscan activity monitor), difference between day 11 (ﬁrst and only
ethanol treatment) and day 2 (saline baseline) in the chronic saline group
[n errors/activity counts/10 min test] by T. J. Phillips and colleagues
8627538 10500 Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan
activity monitor) between acute ethanol on day 3 (ﬁrst ethanol treatment)
and day 2 (saline baseline) in the chronic ethanol group [n errors/activity
counts/10 min test] by T. J. Phillips and colleagues
8627538 10501 Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan
activity monitor) between injection on day 11 (ﬁrst and only ethanol
treatment) and day 2 (saline baseline) in the chronic saline group [errors/
activity counts/10 min test] by T. J. Phillips and colleagues
18830130 11006 Ethanol response (1.75 g/kg ip), ataxia measured by rotarod performance,
difference from saline baseline (supplementary data to Brigman et al.)b y
J. L. Brigman and colleagues
Data can be retrieved at genenetwork.org using the GeneNetwork ID. The PMID links to the primary publication describing the experimental protocol (www.ncbi.nlm.
nih.gov/pubmed/).
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scribed DNA. Each marker SNP was tested for association to BSA
using a regression model. False discovery rate q-values were calcu-
lated by treating each syntenic locus as a separate hypothesis. The
results for each marker are presented in supporting information,
Table S1, and the top associated markers are presented in Table 2.
GPC5 (glypican 5) became the gene of interest due to the statistical
strength of the linkage data in mice and the association data in
humans. The BXD linkage yielded a LOD score of 3.9 (P  
1.25E205), slightly shy of the genome-wide signiﬁcance value of 4.3
(P   5.0E206). Similarly, the multiple test corrected signiﬁcance
value for association to BSA was q ¼ 0.08 (nominal P ¼
7.54E205) very close to the standard q ¼ 0.05 threshold for signiﬁ-
cance. Taken together, these data implicate GPC5 as a candidate QTL
that inﬂuences ethanol-induced ataxia.
To further investigate glypican involvement in ethanol response,
mutant alleles of the Drosophila glypican genes dally and dlp were
investigated to determine whether they alter Drosophila ethanol re-
sponse. The six mammalian glypican genes have two homologs in the
Drosophila genome. Evolutionarily, dally is thought to be orthologous
to the human glypican gene paralogs GPC3 and GPC5, whereas dlp is
orthologous to the other four human glypican paralogs (Filmus et al.
2008). We tested both genes in Drosophila, reasoning that homologous
gene function as measured by something as complex as behavior may
not precisely track with the predicted evolutionary lineage of a gene.
Partial loss-of-function alleles of dlp and dally were used in ethanol
behavioral assays because they were less afﬂicted with the develop-
mental defects and lethality caused by strong loss-of-function alleles.
Stocks containing partial loss-of-function alleles, either dlpf03537 or
dallyMB950, were ﬁrst outcrossed onto the Berlin genetic background
to normalize the genetic background between experimental and con-
trol ﬂies. Each allele contains a transposon inserted into the ﬁrst in-
tron (Figure 2, A and E). dlpf03537 was found to be weakly viable and
sterile as a homozygote but without overt morphological or behavioral
phenotypes. Transcript levels of dlp in ﬂy heads were reduced by 40%
in dlpf03537 heterozygotes (P ¼ 0.0363, n ¼ 3 replicates, two-sample t-
test); dlpf03537 failed to complement dlp1 lethality, strong evidence that
dlpf03537 is a dlp allele. dallyMB950 was found to be homozygous viable
and fertile, and it also had no overt morphological or behavioral
phenotypes. Heads of homozygous dallyMB950 ﬂi e sw e r es h o w nt o
have a 27% reduction in dally transcript (P ¼ 0.0218, n ¼ 5 replicates,
two-sample t-test), but dallyMB950 complemented the sterility and
wing vein morphology phenotypes of the strong loss-of-function allele
dally80. Given the molecular evidence that dallyMB950 is an allele of
dally, a transposon inserted into the gene coupled with reduced tran-
script production, we conclude that intragenic complementation is
occurring because the dallyMB950 allele provides enough function to
complement the phenotype of the strong loss-of-function allele.
Flies carrying the dallyMB950 and dlpf03537 alleles were evaluated for
alterations in their response to ethanol. Three assays were performed:
locomotor stimulation in response to moderate concentrations of
ethanol; sedation in response to higher concentrations of ethanol;
and the acquisition of rapid tolerance to ethanol sedation. Flies ex-
posed to a continuous stream of moderate concentration ethanol
n Table 2 Summary of BXD linkage and human association of the syntenic locus
Mouse Chromosome Phenotype Max LOD
Human
Markers Tested
Maximum
Associated Marker Association q-value Human Genes
14 11006 3.88 476 rs1330469 0.0820 GPC5
1a 10144 2.72 1343 rs790022 0.1360 EFHD1
ALPI
10147 2.48 CHRND
CHRNG
2 10144 2.43 635 rs6077309 0.1510 ANGPT4
RSPO4
FAM110A
3 10498 2.92 335 rs16828127 0.2240 NLGN1
11c 10347 2.41 333 rs9892427 0.2695 ELAC2
18b 10500 2.29 639 rs11875845 0.3970 DCC
1b 10146 2.53 509 rs10515988 0.4040 ZCCHC2
11a 10078 3.36 361 rs9885172 0.6060 SLIT3
6 10042 2.91 244 rs2375016 0.6230 SVOP
10 10500 2.21 163 rs7397470 0.6630 TBK1
XPOT
18a 10147 2.09 704 RS2684847 0.7040 DTNA
11b 10042 3.89 319 RS9892427 0.9800 GRB7
ERBB2
NEUROD2
TCAP
STARD3
PNMT
PPP1R1B
13 10498 2.21 154 rs7716600 0.9950 MRPS30
10500 1.96
10501 1.96
All loci with “suggestive” linkage to at least one BXD ethanol-induced ataxia phenotype are listed. The ﬁrst three columns describe the BXD linkage (see Table 1 to
decipher phenotype code). If a mouse chromosome has more than one linkage signal, the loci are differentiated with a letter after the chromosome number. The next
four columns describe the association results of the human syntenic locus; q-values refer to the marker. All genes that map within 100 kb of the maximum associated
marker are listed.
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When ethanol is ﬁrst introduced, ﬂies show a transient burst of loco-
motor activity—a startle response to the smell of ethanol (Figure 2, B
and F). Activity brieﬂy returns to baseline levels, followed by increas-
ing hyperactivity that coincides with the rising internal concentrations
of ethanol (approximately 25 mM at 25 min exposure). As internal
ethanol concentration increases, ﬂies become progressively more un-
coordinated and eventually they become sedated. Sedation sensitivity
is measured using a higher ethanol dose, 67% vapor, which results in
50% sedation after  20 min exposure in control ﬂies (Figure 2, D and
G). If ethanol-exposed ﬂies are allowed to rest for 3.5 hr to metabolize
absorbed ethanol, reexposed ﬂies take substantially longer to sedate
( 32 min for 50% sedation). This acquired resistance to ethanol
sedation is termed rapid tolerance and is due to neuro-adaptations
to the effects of ethanol intoxication (Scholz et al. 2000; Wolf and
Heberlein 2003).
The ethanol behavioral responses of dlpf03537 and dallyMB950 ﬂies
differed signiﬁcantly from controls, and they were qualitatively similar
to each other. Ethanol-induced locomotor activity in homozygous
mutant ﬂies was the most similar response; both mutant strains, as
homozygotes, showed signiﬁcantly reduced ethanol hyperactivity (Fig-
ure 2, B and F, left panels). Interestingly, heterozygous mutants
showed the opposite result of increased ethanol hyperactivity, but only
dlpf03537 heterozygotes showed a signiﬁcant increase (Figure 2, B and
F, right panels). Given that the expression and complementation
experiments indicate that transcript levels decrease with the number
of mutant alleles, the simple model that ethanol hyperactivity
decreases with decreasing transcript is not supported; a more complex
relationship between dally and dlp gene expression and ethanol hy-
peractivity must exist. dallyMB950 and dlpf03537 mutants were also sim-
ilar in their ethanol sedation sensitivity. Because of the weak viability
of dlpf03537 homozygotes, only heterozygotes were generated in sufﬁ-
cient numbers for the sedation assays. The dlpf03537 heterozygotes
displayed increased sedation sensitivity (Figure 2D). dallyMB950 heter-
ozygotes and homozygotes were both more sensitive to the sedating
effect of ethanol, with the homozygotes exhibiting greater sensitivity
(Figure 2G and data not shown). The two mutants differed in their
development of rapid tolerance [rapid tolerance was measured as the
difference in sedation sensitivity between an initial exposure to etha-
nol, e1, and a second exposure, e2, delivered four hours later (Figure
2C)]. While dlpf03537 heterozygotes developed greater tolerance,
dallyMB950 heterozygotes and homozygotes were indistinguishable
from control ﬂies (Figure 2, D and G). Ethanol absorption was un-
altered in the mutants (Figure 2 legend), so we can conclude that the
behavioral alterations were due to different responses to the same
ethanol dose.
DISCUSSION
Our search for genes inﬂuencing AUD development ﬁrst looked for
genetic linkage in mice, and we discovered 13 candidate QTL
contributing to ethanol-induced ataxia. These hypothetical QTL were
examined for genetic associations with alcohol-induced ataxia in
humans. With candidate loci as a hypothesis, we reduced the number
of statistical tests in comparison with a genome-wide association
Figure 2 Drosophila glypican
homologs regulate behavioral
responses to acute and re-
peated ethanol exposure. (A)
Simpliﬁed diagram of the dlp
locus. Coding regions are in-
dicated with shaded boxes.
The transposon insertion allele
dlpf03537 is located in the ﬁrst
intron. Probes for qPCR span
the last intron. (B) Ethanol-
stimulated locomotion of ﬂies
homozygous (left) or heterozy-
gous (right) for f03537 continu-
ously exposed to 47% ethanol
vapor (0–25 min, bar on hori-
zontal axis). Control in all
experiments was the genetic
background strain. Statistical
signiﬁcance (two-sample t-test)
was assessed by comparison
of the total distance traveled
during the hyperactive phase
(2–25 min). f03537:n¼ 5,
f03537/+: n ¼ 8. (C) Exposure
scheme for inducing and
detecting ethanol rapid toler-
ance. Flies were exposed twice
to 67% ethanol vapor with 4 hr between the start of exposures 1 and 2. (D) Sedation sensitivity and tolerance of ﬂies heterozygous for f03537.
ST50 is the time to 50% sedation, and sedation tolerance is the difference between the ST50 of exposure 2 (e2) and 1 (e1). Sensitivity and sedation
are illustrated by the horizontal bar graphs.  P ¼ 0.0206,   P ¼ 0.0022, two-sample t-test. n ¼ 9. (E) Simpliﬁed diagram of the dally locus. (F)
Ethanol-stimulated locomotion of ﬂies homozygous (left) or heterozygous (right) for MB950 continuously exposed to 47% ethanol vapor
(0–25 min). MB950:n¼ 7, MB950/+: n ¼ 11. (G) Sedation sensitivity and tolerance of ﬂies homozygous for MB950.    P ¼ 0.0002, two-sample
t-test. n ¼ 7. Ethanol absorption was unaltered in dlp (control: 24.6 mM, f03537/+: 24.2 mM, P ¼ 0.8726, two-sample t-test, n ¼ 6) and dally
mutant ﬂies (control: 29.5 mM, MB950: 31.7 mM, P ¼ 0.5231, two-sample t-test, n ¼ 4).
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associations at the human loci. We also obtained greater genetic
resolution and human relevance.
Human genetic association identiﬁed GPC5, a member of the
glypican gene family, to be of statistical interest with a multiple-test–
corrected FDR q-value of 0.082. We then moved to a Drosophila
model system to obtain correlative evidence in an experimental system
where mutations can be introduced and tested for their effect on
ethanol-induced behaviors. The Drosophila results supported the
mammalian genetic results by demonstrating that ﬂies carrying mu-
tant alleles of dally or dlp,t h eDrosophila homologs of mammalian
glypicans, exhibit alterations in ethanol-induced locomotor activity,
ethanol-induced sedation, and rapid tolerance to ethanol-induced se-
dation. Together, these results strongly implicate GPC5 as a contribu-
tor to ethanol response.
The mammalian glypicans (GPC1 to GPC6) are heparan sulfate
proteoglycans (HSPG) linked to the cell surface via a glycosylphos-
phatidylinositol (GPI) anchor. Much of what we know about glypican
function in mammals was founded upon Drosophila experiments in-
vestigating dally and dlp, orthologs of the mammalian 3/5 subfamily
and the 1/2/4/6 subfamily, respectively [reviews in Filmus et al. (2008)
and Wu et al. (2010)]. Glypicans are involved in modulating cellular
signaling, participating in many aspects of normal morphogenesis
(including neuronal development and axon guidance) where they
regulate the signaling of the Wnt, Hedgehog, ﬁbroblast growth factor
(FGF), and bone morphogenetic protein (BMP) ligands. Consistent
with this role in developmental signaling, dysregulation of glypicans
has been detected in various cancers (Filmus 2001).
GPC5 is developmentally expressed in a pattern consistent with its
involvement in central nervous system, limb, and kidney development
(Saunders et al. 1997). Because acute ethanol response is brain medi-
ated, only brain expression patterns in mice were considered here in
detail. Unlike the majority of glypican family members where expres-
sion in embryonic brain is much greater than in adult brain, GPC5
brain expression increases with embryonic age and is highest in adult
tissue (Luxardi et al. 2007). GPC59s embryonic brain expression is also
more spatially restricted than the other glypicans; it is limited to the
striatum primordium and ventral diencephalic wall starting about day
10 of embryogenesis (Luxardi et al. 2007). In adults, the greatest
expression is seen in the caudate nucleus, the putamen, and the hip-
pocampus (Saunders et al. 1997), structures thought to play a signiﬁ-
cant role in drug behavior (Koob and Volkow 2010). In ﬂies, both
dally and dlp are expressed in the nervous system during development
and in adulthood (Chintapalli et al. 2007).
In addition to being expressed in brain regions thought to play
a role in ethanol response, there is evidence that GPC5 transcription
can be modulated by ethanol. After discovering that ethanol-induced
expression of Gabra4 in mouse cortical neurons is dependent upon
the activation of heat shock factor 1 (HSF1) and its binding to an
ethanol response sequence element located between exons 1 and 2,
Pignataro et al. (2007) performed a microarray screening experiment
to identify additional genes whose transcription is activated by ethanol
via HSF1. By exposing cortical neurons to ethanol or heat and using
microarrays to identify genes whose expression was altered by the
treatment, they identiﬁed 50 genes that were transcriptionally upregu-
lated in response to ethanol and  450 genes upregulated in response
to heat. The authors highlighted the 9 genes that responded “dramat-
ically” (upregulated 50% or greater) to both treatments, a list that
includes GPC5. Additionally, we previously found that Drosophila
dally expression was transiently increased following exposure to a se-
dating dose of ethanol (Kong et al. 2010).
Glypicans have been shown to participate in organismal de-
velopment through their interactions with the Wnt, Hedgehog, FGF,
and BMP morphogen signaling pathways (Selleck 2000). These de-
velopmental pathways have more recently been implicated not only in
neural development but also in postdevelopmental synaptic mainte-
nance and plasticity, making them credible participants in neurolog-
ical, psychiatric, and behavioral phenotypes (Budnik and Salinas 2011;
Farías et al. 2010; Ille and Sommer 2005; Marqués 2005; Okerlund and
Cheyette 2011; Salinas 2005). We hypothesize that glypicans modulate
these pathways in their neurological functions as they do in their
developmental functions. Whereas, prior to this report, there was
no experimental literature addressing glypicans’ role in behavior, there
are reports of glypicans being involved in human psychiatric condi-
tions: GPC6 is associated with a neuroticism using an age-by-SNP
interaction model (Calboli et al. 2010), and GPC1 is a member of
a schizophrenia gene network derived from a gene set enrichment
analysis of GWA data (Potkin et al. 2010).
In summary, we presented evidence that the glypican GPC5
participates in human ethanol response, an endophenotype related to
AUD risk. The strength of the evidence is derived from the
coalescence of results across different experimental systems: mouse
linkage identiﬁed the candidate locus, human genetic association
identiﬁed a single gene contained within the mouse-deﬁned locus, and
Drosophila behavioral experiments demonstrated that mutant alleles
of the gene identiﬁed in mice and humans alter the ﬂy’s ethanol re-
sponse. In addition to our analyses, the literature on GPC5 reports its
expression to be spatially and temporally consistent with a putative
involvement in ethanol behaviors, and moreover, its expression can be
modulated by ethanol. Finally, the known functions of glypicans as
modulators of cell signaling systems that participate in neural devel-
opment as well as synaptic maintenance and plasticity are also con-
sistent with participation in ethanol-induced behaviors. GPC5 is thus
a strong candidate as a gene involved in ethanol response and the
development of alcohol use disorders.
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